Pierre G. Coulie - Concepedia

Author

Pierre G. Coulie

Also Known As

K. Missault, P Coulie, P G Coulie, P. COULIE, P. Coulie, P. G. COULIE, P. G. Coulie, P.G. Coulie, PIERRE COULIE, PIERRE G. COULIE

352

Publications

21.7K

Citations

H-Index

138

Concepts

All Affiliations

UCLouvain Ludwig Cancer Research de Duve Institute Cliniques Universitaires Saint-Luc Inserm

About

Pierre G. Coulie is an author at UCLouvain specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	67	10.9K
2	Allergy	7	7	500
3	Natural Sciences	5	5	341
4	Education	1	1	35
5	Health Sciences	1	1	965

Pierre G. Coulie

138

Publications

17K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, European Journal of Immunology Laboratory ImmunologyImmunologyPathologyImmunophenotypingImmune System	2019	965
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. Vincent Brichard, Aline Van Pel, Thomas Wölfel, The Journal of Experimental Medicine HistocompatibilityImmunologyPathologyTyrosinase GeneAntigen Processing	1993	956
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. Pierre G. Coulie, Vincent Brichard, Aline Van Pel, The Journal of Experimental Medicine HistocompatibilityLymphocyte DevelopmentHla ImmunogeneticsImmunologyPathology	1994	914
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1 Marie Marchand, Nicolas van Baren, P. Weynants, International Journal of Cancer Subcutaneous InjectionsImmunologyImmunoeditingPathologyImmunotherapeutics	1999	786
Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor Hideyuki Ikeda, Bernard Lethé, Frédéric Lehmann, Immunity Tumor ImmunologyCancer ImmunosurveillanceNk Inhibitory ReceptorImmunologyMelanoma	1997	765
Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Jacques Van Snick, Sylvie Cayphas, Anne Vink, Proceedings of the National Academy of Sciences Lymphoid NeoplasiaB-cell HybridomasGrowth Factor ActivityT-cell-derived LymphokineLaboratory Immunology	1986	685
BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes Pascale Boël, Claude Wildmann, Marialuisa Sensi, Immunity New GeneMelanomaImmunologyHuman MelanomasPathology	1995	590
A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Pierre G. Coulie, Frédéric Lehmann, Bernard Lethé, Proceedings of the National Academy of Sciences Cancer ImmunosurveillanceHuman MelanomaMedicineMelanomaImmunology	1995	419
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death Abhishek D. Garg, Lorenzo Galluzzi, Lionel Apétoh, Frontiers in Immunology ApoptosisImmunologyCell DeathImmunologic MechanismAntigen Processing	2015	381
A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3 Pierre van der Bruggen, Judy Bastin, Thomas F. Gajewski, European Journal of Immunology	1994	370

Page 1